These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 11362426)

  • 1. 3TC: the good news and the bad news.
    Cheng B
    PI Perspect; 1995 May; (no 16):4. PubMed ID: 11362426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3TC/AZT: just another combination.
    GMHC Treat Issues; 1995 Dec; 9(12):2. PubMed ID: 11362997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AZT + 3TC: early results promising.
    Colvin R; Haas G
    Common Factor; 1995 Apr; (no 10):16. PubMed ID: 11362341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zidovudine and lamivudine: results of phase III studies.
    Staszewski S
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 1():S57. PubMed ID: 8595510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AZT and 3TC.
    Treat Rev; 1996 Apr; (no 21):4. PubMed ID: 11363395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lamivudine (3TC) approved for combination use with AZT.
    James JS
    AIDS Treat News; 1995 Dec; (no 236):1-5. PubMed ID: 11363049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination 3TC/AZT therapy shows promise.
    AIDS Clin Care; 1995 Mar; 7(3):22. PubMed ID: 11362192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AZT studies reinforce benefits of combination.
    AIDS Alert; 1995 Jan; 10(1):11-2. PubMed ID: 11362167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Major protease inhibitor triple combination trial begins soon: CD4 under 200, AZT experienced, 3TC naive.
    James JS
    AIDS Treat News; 1995 Dec; (no 237):3. PubMed ID: 11363075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3TC and AZT.
    Treat Rev; 1995; (no 17):2. PubMed ID: 11362294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potent new AIDS drugs underscore promise of combination therapy.
    AIDS Alert; 1996 Jan; 11(1):1-4. PubMed ID: 11363225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Another option for less than 50 T4 cells.
    Treat Rev; 1995; (no 19):3. PubMed ID: 11362755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3TC approved: now for the tough questions.
    Mascolini M
    J Int Assoc Physicians AIDS Care; 1995 Dec; 1(11):6-8. PubMed ID: 11363101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A closer look at 3TC. Interview by Mark Mascolini.
    Rubin M
    J Int Assoc Physicians AIDS Care; 1995 Jul; 1(6):21-5. PubMed ID: 11362724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3TC approval may revive AZT's appeal.
    Vazquez E
    Posit Aware; 1996; 7(1):8-9. PubMed ID: 11363136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Merck protease inhibitor: more news from Retroviruses Conference.
    James JS
    AIDS Treat News; 1996 Feb; (no 241):1-3. PubMed ID: 11363186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3TC: now available again up to CD4 of 300.
    AIDS Treat News; 1995 Aug; (no 228):4. PubMed ID: 11362624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benefits of combination therapy confirmed.
    Cheng B
    PI Perspect; 1995 Dec; (no 17):3-4. PubMed ID: 11363111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3TC and saquinavir: we need them now.
    Baker R
    BETA; 1995 Sep; ():3. PubMed ID: 11362889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiretroviral combination treatment prolongs life in people with HIV/AIDS.
    Cooper EC
    AMFAR Rep; 1996 Jan; ():1-5. PubMed ID: 11363617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.